You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ipilimumab

Showing 901 - 914 of 914
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Kidney Cancer Trial run by the CC (ipilimumab)

Completed
  • Kidney Cancer
  • ipilimumab
  • Bethesda, Maryland
    Warren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Mar 14, 2012

Melanoma Trial (Ipilimumab, Interferon, Interleukin-2 (Aldesleukin))

Withdrawn
  • Melanoma
  • Ipilimumab
  • +2 more
  • (no location specified)
Jan 25, 2012

Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC) Trial in Nice,

Unknown status
  • Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)
  • Metformin Group
  • Nice, Alpes-Maritimes, France
  • +1 more
Apr 23, 2013

Melanoma Trial in United States (AntiCD137, Ipilimumab)

Withdrawn
  • Melanoma
  • Los Angeles, California
  • +6 more
Nov 18, 2011

Melanoma Trial in United States (CP-675,206)

Completed
  • Melanoma
  • Scottsdale, Arizona
  • +7 more
Jun 5, 2012

Carcinoma, Renal Cell Trial in United States (CP-675,206, SU011248)

Completed
  • Carcinoma, Renal Cell
  • Scottsdale, Arizona
  • +4 more
Jun 5, 2012

Malignant Melanoma Trial in United States (CP-675,206)

Completed
  • Malignant Melanoma
  • Los Angeles, California
  • +8 more
Jun 5, 2012

Breast Cancer, Adenocarcinoma Trial in United States (MDX-010)

Completed
  • Breast Cancer
  • Adenocarcinoma
  • San Diego, California
  • +13 more
Apr 26, 2012

Melanoma, Metastases Trial in Worldwide (MDX-010 (anti-CTLA4) mAb, MDX-1379 (gp100) Melanoma Peptide Vaccine)

Completed
Has Results
  • Melanoma
  • Metastases
  • MDX-010 (anti-CTLA4) monoclonal antibody
  • MDX-1379 (gp100) Melanoma Peptide Vaccine
  • Tucson, Arizona
  • +208 more
Jun 29, 2011

Prostate Cancer Trial in United States (MDX-010 / MDX-010 + Docetaxel)

Completed
  • Prostate Cancer
  • MDX-010 / MDX-010 + Docetaxel
  • Tucson, Arizona
  • +10 more
Jun 23, 2011

Melanoma Trial in United States (MDX-010 (CTLA-4))

Completed
  • Melanoma
  • MDX-010 (CTLA-4)
  • Tucson, Arizona
  • +8 more
Jan 20, 2011

Melanoma Trial in Worldwide (ipilimumab (MDX-010, BMS-734016), Ipilimumab)

Completed
  • Melanoma
  • ipilimumab (MDX-010, BMS-734016)
  • Ipilimumab
  • Tucson, Arizona
  • +61 more
Feb 27, 2010

Long-term Data Collection for Subjects in MDX-010 Studies

Completed
  • Metastatic Melanoma
    • Tuscon, Arizona
    • +10 more
    Apr 23, 2010

    Malignant Melanoma Trial in United States (MDX-010)

    Completed
    • Malignant Melanoma
    • MDX-010
    • Tucson, Arizona
    • +3 more
    Apr 23, 2010